
Celltrion gets interchangeability approval for biosimilar of Humira in US
Seoul, April 14 (IANS) Celltrion, a major South Korean biopharmaceutical firm, on Monday said it has obtained an interchangeability approval for its biosimilar drug for autoimmune disease treatment in the… Continue reading Celltrion gets interchangeability approval for biosimilar of Humira in US